 |
市場調査レポート
商品コード
1461443
HIV診断検査市場：製品タイプ別、エンドユーザー別、地域別HIV Diagnostics Test Market, By Product, By Test Type, By End User, By Geography |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| HIV診断検査市場：製品タイプ別、エンドユーザー別、地域別 |
|
出版日: 2024年03月21日
発行: Coherent Market Insights
ページ情報: 英文 120 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
HIV診断検査市場は、2024年には44億4,000万米ドルと推定され、2024年から2031年にかけてCAGR9.2％で成長し、2031年には82億4,000万米ドルに達すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023 | 2023/2024年の市場規模 | 44億4,000万米ドル |
| 実績データ | 2019年から2023年まで | 予測期間 | 2024年から2031年 |
| 予測期間2023/2024～2030/2031 CAGR： | 9.20% | 2030/2031年の予測値 | 82億4,000万米ドル |
HIV診断検査市場シェア（%）、地域別、2024年
HIV診断検査市場は過去数十年にわたって大きな成長を遂げており、今後も大幅な成長が見込まれます。これは主に、世界的にHIV/AIDSの影響を受ける人が増加しているためです。HIV感染を早期に発見することは、病気の蔓延を抑える上で重要な役割を果たすだけでなく、タイムリーに治療を開始することで感染者の生活の質を向上させる。診断技術の進歩により、迅速で簡便なポイントオブケアHIV検査キットの開発が可能になり、あらゆる環境におけるHIV検査サービスへのアクセスが向上しています。
市場力学：
世界のHIV診断検査市場の成長は、世界のHIV/AIDS感染率の上昇に牽引されています。WHOによると、2020年には約3,800万人がHIVとともに生活しています。HIV/AIDS診断・管理に関する政府の好意的な取り組みや規制も市場成長を後押ししています。しかし、発展途上国におけるHIV/AIDSに対する認識不足や、この病気に関連する社会的偏見が、診断検査の普及を妨げています。一方、感度が向上し、診断までの時間が短縮された新しい診断プラットフォームの開発に向けて研究開発が進められていることは、市場に複数の成長機会をもたらしています。
本調査の主な特徴
- 本レポートでは、世界のHIV診断検査市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模（BNドル）および複合年間成長率（CAGR%）を掲載しています。
- さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリックスについて説明しています。
- また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
- 企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいて、世界のHIV診断検査市場の主要企業をプロファイルしています。
- 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
- この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
- 利害関係者は、世界のHIV診断薬検査市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
- Coherent Opportunity Map（COM）
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場機会
- 影響分析
- 市場動向
- 最近の動向
- 買収と提携のシナリオ
- テクノロジーの概要
- 規制シナリオ
- PEST分析
第4章 HIV診断検査市場- コロナウイルス（COVID-19）パンデミックの影響
- 全体的な影響
- 需要と供給への影響
- COVID-19市場への影響
第5章 HIV診断検査市場、製品別、2019年-2031年、
- アッセイキット
- 消耗品
第6章 HIV診断検査市場、検査タイプ別、2019年-2031年、
- 抗体検査
- 抗原/抗体検査
- 核酸検査
第7章 HIV診断検査市場、エンドユーザー別、2019年-2031年、
- 病院・クリニック
- 診断検査室
- ホームケア設定
- その他
第8章 HIV診断検査市場、地域別、2019年-2031年、
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他ラテンアメリカ
- 欧州
- 英国
- ドイツ
- イタリア
- フランス
- スペイン
- ロシア
- その他欧州
- アジア太平洋地域
- 中国
- インド
- 日本
- ASEAN
- オーストラリア
- 韓国
- その他アジア太平洋地域
- 中東
- 湾岸協力会議
- イスラエル
- その他中東
- アフリカ
- 北アフリカ
- 中央アフリカ
- 南アフリカ
第9章 競合情勢
- Abbot
- Bio-Rad Laboratories Inc.
- Hologic Inc.
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter Inc.
- OraSure Technologies Inc.
- Becton Dickinson and Company
- Merck KGaA
- Biosynex SA
- Zyomyx Incorporation
- Bristol-Myers Squibb
- Janssen Pharmaceutica NV
- QIAGEN N.V.
- ViiV Healthcare Ltd.
第10章 アナリストの視点
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
第11章 参考文献と調査手法
- 参考文献
- 調査手法
目次
Product Code: CMI422
The HIV Diagnostics Test Market is estimated to be valued at USD 4.44 Bn in 2024 and is expected to reach USD 8.24 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 4.44 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 9.20% | 2030/2031 Value Projection: | US$ 8.24 Bn |
HIV Diagnostics Test Market Share (%), By Region, 2024
The HIV diagnostics test market has seen significant growth over the past few decades and is expected to grow substantially going forward. This is mainly due to the rise in number of people impacted by HIV/AIDS globally. Early detection of HIV infection plays a vital role in controlling the spread of the disease as well as improves the quality of life of infected individuals with timely treatment initiation. Advancements in diagnostic technologies have enabled development of rapid, simple, and point-of-care HIV testing kits which have improved accessibility and uptake of HIV testing services across all settings.
Market Dynamics:
The global HIV diagnostics test market growth is driven by the rising prevalence of HIV/AIDS infections worldwide. According to WHO, around 38 million people were living with HIV in 2020. Favorable government initiatives and regulations regarding HIV/AIDS diagnosis & management also boost the market growth. However, lack of awareness about HIV/AIDS in developing nations and social stigma associated with the disease hamper widespread adoption of diagnostic tests. On the other hand, ongoing R&D towards development of novel diagnostic platforms with enhanced sensitivity and shorter turn-around-time presents multiple growth opportunities in the market.
Key Features of the Study:
- This report provides in-depth analysis of the global HIV diagnostics test market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global HIV diagnostics test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Abbott, Bio-Rad Laboratories Inc., Hologic Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., OraSure Technologies Inc., Becton Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems Inc., Zyomyx Incorporation, Bristol -Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market.
Market Segmentation
- Product:
- Assay Kit
- Consumables
- Test Type:
- Antibody Test
- Antigen/antibody tests
- Nucleic Acid Test
- End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Homecare Settings
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Abbott
- Bio-Rad Laboratories Inc.
- Hologic Inc.
- Siemens Healthineers
- Hoffmann-La Roche Ltd.
- Beckman Coulter Inc.
- OraSure Technologies Inc.
- Becton Dickinson and Company
- Merck KGaA
- Chembio Diagnostic Systems Inc.
- Zyomyx Incorporation
- Bristol -Myers Squibb
- Janssen Pharmaceutica NV
- QIAGEN N.V.
- ViiV Healthcare Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
4. HIV Diagnostics Test Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. HIV Diagnostics Test Market, By Product, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Assay Kit
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
6. HIV Diagnostics Test Market, By Test Type, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Antibody Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Antigen/antibody tests
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Nucleic Acid Test
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
7. HIV Diagnostics Test Market, By End User, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Homecare Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
8. HIV Diagnostics Test Market, By Region, 2019 - 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Abbot
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hologic Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Beckman Coulter Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OraSure Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biosynex SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zyomyx Incorporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol -Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Pharmaceutica NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViiV Healthcare Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
